Lupin gets USFDA nod for chemotherapy-associated nausea and vomiting injection

Lupin gets USFDA nod for chemotherapy-associated nausea and vomiting injection The company has received approval from the United States Food and Drug Administration (USFDA) for its Fosaprepitant for injection, 150 mg single-dose vial, Lupin said in a statement.

No comments:

Post a Comment